icon-    folder.gif   Conference Reports for NATAP  
 
  21st Conference on Retroviruses and
Opportunistic Infections
Boston, MA March 3 - 6, 2014
Back grey_arrow_rt.gif
 
 
 
CMV and HIV: A Double Hit On the CD4/CD8 Ratio
 
 
  from Jules: HCV & Peg-Inf may also have an affect on immunosenescence, research has reported this. So for connected this could be a triple hit.
 
CROI: CD4:CD8 Ratio Remains Significantly Depressed Despite Viral Suppression With Effective ART - (04/02/14)
 
CROI: A Low CD4/CD8 Ratio During Effective ART Predicts Immunosenescence and Morbidity/Mortality - (04/02/14)
 
21st Conference on Retroviruses and Opportunistic Infections Boston MA March 3 - 6, 2014
 
CROI: Summary from CROI 2014 for Hepatitis HCV direct acting antivirals (DAAs) in HCV and HIV/HCV coinfection: same outcome? Which DAA regime will allow for the shortest treatment duration? - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany (03/20/14)
 
CROI: HCV Coverage at CROI - (03/10/14)
 
Reported by Jules Levin
CROI 2014 March 3-6
Boston, MA
 
Talia Sainz1, Sergio Serrano-Villar2, Sulggi A. Lee3, Peter W. Hunt3, Elizabeth Sinclair3, Jeffrey N. Martin3, Joseph M. McCune3, Steven G. Deeks3 1Molecular Immune Biology Laboratory, University Hospital Gregorio Maranon, Madrid, Spain, 2Molecular Immune Biology Laboratory, University Hospital Ramon y Cajal, Madrid, Spain, 3University of California San Francisco, San Francisco, CA, United States

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif